Trials / Completed
CompletedNCT02997267
Early Closure of Protective Ileostomy in Rectal Cancer Patients
The Early Closure of the Protective Ileostomy After Low Anterior Resection Enables Correct Start of Chemotherapy
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 58 (actual)
- Sponsor
- Stanley Dudrick's Memorial Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The aim of the study was to compare the restoration of the GI tract by the closure of protective ileostomy after low anterior resection for rectal cancer after 14 days and more than 3 months.
Detailed description
The closure of the protective ileostomy created during the low anterior resection for rectal cancer to protect the colo-rectal anastomosis is inevitable to restore the continuity of the gastrointestinal tract. It usually takes place several months after the primary surgery, because the patients starts chemotherapy and cannot undergo the procedure during the therapy. It results in the relative low quality of life of the patient, as well as often leads to complications. Therefore, it seem reasonable to close the stoma as soon as possible to take the burden off patient. It is well known that the healing process of the anastomosis runs in the three phases, but only two first are crucial for the clinical result. The second takes place between 5th and 14th postoperative day. Therefore it should be possible to perform successful restoration of the GI tract already after two weeks after operation, and not after many moths. The aim of the study was to compare the restoration of the GI tract after 14 days and more than 3 months, so to compare the traditional and early strategy.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Closure of the ileostomy | Surgical closure of the protective ileostomy (reconnection of intestinal loops) |
Timeline
- Start date
- 2016-10-01
- Primary completion
- 2017-03-01
- Completion
- 2017-12-31
- First posted
- 2016-12-20
- Last updated
- 2018-04-03
Locations
1 site across 1 country: Poland
Source: ClinicalTrials.gov record NCT02997267. Inclusion in this directory is not an endorsement.